Anna Czarnecka

403 total citations
23 papers, 317 citations indexed

About

Anna Czarnecka is a scholar working on Cellular and Molecular Neuroscience, Neurology and Physiology. According to data from OpenAlex, Anna Czarnecka has authored 23 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 10 papers in Neurology and 8 papers in Physiology. Recurrent topics in Anna Czarnecka's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Nitric Oxide and Endothelin Effects (6 papers). Anna Czarnecka is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Nitric Oxide and Endothelin Effects (6 papers). Anna Czarnecka collaborates with scholars based in Poland, United States and Denmark. Anna Czarnecka's co-authors include Elżbieta Lorenc‐Koci, Jolanta Konieczny, Tomasz Lenda, Magdalena Zielińska, Jan Albrecht, Helena Domin, Maria Śmiałowska, Marta Obara‐Michlewska, Maria Siemionow and Anna Domaszewska-Szostek and has published in prestigious journals such as Brain Research, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Anna Czarnecka

23 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Czarnecka Poland	12	106	103	89	54	42	23	317
Vera Fridman United States	9	93 0.9×	116 1.1×	99 1.1×	115 2.1×	44 1.0×	18	343
Siyue Li China	11	59 0.6×	49 0.5×	132 1.5×	38 0.7×	41 1.0×	25	378
Iuri Domingues Della-Pace Brazil	10	65 0.6×	58 0.6×	128 1.4×	81 1.5×	39 0.9×	12	327
Tony Jer‐Fu Lee United States	12	65 0.6×	137 1.3×	176 2.0×	155 2.9×	41 1.0×	23	448
Daniel Havas United States	11	83 0.8×	71 0.7×	76 0.9×	151 2.8×	44 1.0×	20	293
Onésia Cristina Oliveira‐Lima Brazil	11	43 0.4×	97 0.9×	141 1.6×	57 1.1×	128 3.0×	20	429
Jessica D’Amico Italy	9	75 0.7×	109 1.1×	209 2.3×	70 1.3×	18 0.4×	14	334
Chinchusha Anasooya Shaji United States	11	117 1.1×	28 0.3×	159 1.8×	60 1.1×	143 3.4×	23	420
Veerle Bogaerts Belgium	8	206 1.9×	114 1.1×	227 2.6×	230 4.3×	82 2.0×	10	522

Countries citing papers authored by Anna Czarnecka

Since Specialization

Citations

This map shows the geographic impact of Anna Czarnecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Czarnecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Czarnecka more than expected).

Fields of papers citing papers by Anna Czarnecka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Czarnecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Czarnecka. The network helps show where Anna Czarnecka may publish in the future.

Co-authorship network of co-authors of Anna Czarnecka

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Czarnecka. A scholar is included among the top collaborators of Anna Czarnecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Czarnecka. Anna Czarnecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Czarnecka, Anna, et al.. (2023). Attenuation of initial pilocarpine‐induced electrographic seizures by methionine sulfoximine pretreatment tightly correlates with the reduction of extracellular taurine in the hippocampus. Epilepsia. 64(5). 1390–1402. 1 indexed citations

Obara‐Michlewska, Marta, Anna Czarnecka, Stanisław J. Czuczwar, et al.. (2021). Pretreatment with a glutamine synthetase inhibitor MSO delays the onset of initial seizures induced by pilocarpine in juvenile rats. Brain Research. 1753. 147253–147253. 7 indexed citations

Aldana, Blanca I., et al.. (2021). Inhibition of Glutamate Release, but Not of Glutamine Recycling to Glutamate, Is Involved in Delaying the Onset of Initial Lithium-Pilocarpine-Induced Seizures in Young Rats by a Non-Convulsive MSO Dose. International Journal of Molecular Sciences. 22(20). 11127–11127. 3 indexed citations

Domaszewska-Szostek, Anna, et al.. (2021). Local Treatment of Burns with Cell-Based Therapies Tested in Clinical Studies. Journal of Clinical Medicine. 10(3). 396–396. 18 indexed citations

Czarnecka, Anna, Wojciech Hilgier, & Magdalena Zielińska. (2020). S-Adenosylmethionine Deficiency and Brain Accumulation of S-Adenosylhomocysteine in Thioacetamide-Induced Acute Liver Failure. Nutrients. 12(7). 2135–2135. 6 indexed citations

Czarnecka, Anna, et al.. (2020). The Status of Bile Acids and Farnesoid X Receptor in Brain and Liver of Rats with Thioacetamide-Induced Acute Liver Failure. International Journal of Molecular Sciences. 21(20). 7750–7750. 11 indexed citations

Obara‐Michlewska, Marta, et al.. (2018). Persistent Overexposure to N-Methyl-d-Aspartate (NMDA) Calcium-Dependently Downregulates Glutamine Synthetase, Aquaporin 4, and Kir4.1 Channel in Mouse Cortical Astrocytes. Neurotoxicity Research. 35(1). 271–280. 27 indexed citations

Lenda, Tomasz, et al.. (2017). Depressive-like neurochemical and behavioral markers of Parkinson’s disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle. Pharmacological Reports. 69(5). 985–994. 41 indexed citations

Konieczny, Jolanta, Tomasz Lenda, & Anna Czarnecka. (2016). Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats. Neuroscience. 324. 92–106. 11 indexed citations

10.

Lorenc‐Koci, Elżbieta, et al.. (2016). Contribution of the nitric oxide donor molsidomine and the antiparkinsonian drug l-DOPA to the modulation of the blood pressure in unilaterally 6-OHDA-lesioned rats. Pharmacological Reports. 69(1). 29–35. 2 indexed citations

11.

Czarnecka, Anna, et al.. (2016). Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?. Neurochemical Research. 42(3). 750–761. 14 indexed citations

12.

Konieczny, Jolanta, et al.. (2016). The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA. Neuroscience. 340. 308–318. 14 indexed citations

13.

Czarnecka, Anna, et al.. (2016). Intracerebral Administration of S-Adenosylhomocysteine or S-Adenosylmethionine Attenuates the Increases in the Cortical Extracellular Levels of Dimethylarginines Without Affecting cGMP Level in Rats with Acute Liver Failure. Neurotoxicity Research. 31(1). 99–108. 8 indexed citations

14.

Konieczny, Jolanta, et al.. (2015). Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: Comparison to the classical neurotoxin 6-OHDA. Behavioural Brain Research. 283. 203–214. 8 indexed citations

15.

Czarnecka, Anna, Jolanta Konieczny, Tomasz Lenda, & Elżbieta Lorenc‐Koci. (2015). The preferential nNOS inhibitor 7-nitroindazole and the non-selective one NG-nitro-l-arginine methyl ester administered alone or jointly with l-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats. Brain Research. 1625. 218–237. 2 indexed citations

16.

Konieczny, Jolanta, Danuta Jantas, Tomasz Lenda, et al.. (2014). Lack of Neuroprotective Effect of Celastrol Under Conditions of Proteasome Inhibition by Lactacystin in In Vitro and In Vivo Studies: Implications for Parkinson’s Disease. Neurotoxicity Research. 26(3). 255–273. 36 indexed citations

17.

Konieczny, Jolanta, et al.. (2013). Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra. Behavioural Brain Research. 261. 79–88. 20 indexed citations

18.

Czarnecka, Anna, Tomasz Lenda, Helena Domin, et al.. (2013). Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: The effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine. Brain Research. 1541. 92–105. 20 indexed citations

19.

Lorenc‐Koci, Elżbieta, et al.. (2013). Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA. Neurochemistry International. 63(8). 790–804. 22 indexed citations

20.

Lorenc‐Koci, Elżbieta & Anna Czarnecka. (2013). Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models. Pharmacological Reports. 65(5). 1043–1055. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact